ABCC1 and breast carcinoma: The involvement of ABCC1 in drug resistance has been documented in various cancers, including acute myeloblastic and lymphoblastic leukemia, prostate cancer, non-small-cell lung cancer, neuroblastoma, and breast carcinoma [63,98,99].